跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BPO5 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BPO5
Authorized
STANDARD
BPO5
rgr pharma ltd.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6289cdeb9d4275dd
Company
rgr pharma ltd.
Type
Standard
Approval Details
Approval Id
6289cdeb9d4275dd
Drug Approval Canada Name
BPO5
Product Name
BPO5
Status
Marketed
Status Date
2020-04-03
Original Market Date
2020-04-03
Din
02490285
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:28.00
Atc Original
D10AE01 BENZOYL PEROXIDE
Atc Name
d 10 ae 01
Aig Number
0107205001
Company Name
rgr pharma ltd.
Company Address
6220 Westar Drive, La Salle, Ontario, Canada, N9J 0B5
Active Ingredients
BENZOYL PEROXIDE
5 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6289cdeb9d4275dd
Type
Standard
Back to Health Canada Approvals